Ontology highlight
ABSTRACT: Background
Limited data exist on the burden of respiratory syncytial virus (RSV) illness among pregnant women, to determine their potential benefit from RSV vaccination. We evaluated the incidence of RSV illness from midpregnancy until 24 weeks postpartum in human immunodeficiency virus (HIV)-uninfected and HIV-infected women and their infants.Methods
Mother-infant dyads were enrolled in maternal influenza vaccine efficacy trials. These included 1060 and 1056 HIV-uninfected pregnant women in 2011 and 2012, respectively, 194 HIV-infected pregnant women in 2011, and their infants. Upper respiratory tract samples obtained at illness visits were tested for RSV.Results
The incidence (per 1000 person-months) of RSV illness (n = 43 overall) among HIV-uninfected women was l
SUBMITTER: Madhi SA
PROVIDER: S-EPMC5961360 | biostudies-literature | 2018 May
REPOSITORIES: biostudies-literature